Search - tctmd.com

Displaying 41 - 60 of 179

Sort: Relevancy | Date

Presentation TCT 2024

TCT 774: Gender Differences in Prevalence, Clinical Presentation, Management Strategies and Clinical Outcomes of Valvular Heart Disease in Hospitalized Patients

Presenter: Hiteshi Chauhan

October 27, 2024

Presentation TCT 2024

TCT 609: Mortality Trends Due to Non-Rheumatic Valvular Disease Among Adults in the United States From Year 1999-2020: CDC WONDER Database Survey Analysis

Presenter: Mobeen Haider

October 27, 2024

Presentation TCT 2023

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Presenter: Thomas Waggoner

October 26, 2023

Presentation TCT 2023

TCT 630: Mitral Transcatheter Edge-to-Edge Repair in Multiple Valvular Heart Disease: Outcomes With Combined Aortic Insufficiency and Mitral Regurgitation

Presenter: Ahmad Mustafa

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Presenter: Yeonwoo Choi

September 19, 2022

Presentation TCT 2022

Using AI-Based Analysis of ECGs and Multimodality Datasets to Improve Diagnosis of Valvular Heart Disease, Cardiac Amyloidosis, and Heart Failure

Presenter: Timothy Joseph Poterucha

September 19, 2022

News Conference News TCT 2022

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

Caitlin E. Cox

September 16, 2022

Presentation TCT 2022

Hemodynamics for Valvular Heart Disease 101: Recognizing Hemodynamics Associated With Valve Disease

Presenter: David Blusztein

September 16, 2022

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

Presentation TCT 2021

What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR?

Presenter: Robert Bonow

November 05, 2021

Presentation TCT 2021

Case Outcome

Presenter: Tom Cahill

November 04, 2021

Presentation TCT 2021

What the Guidelines Say

Presenter: Stephan Baldus

November 04, 2021

Presentation TCT 2021

Case Presentation: 79-Year-Old Woman With Mechanical MVR, Severe TR and Early RV Dysfunction

Presenter: Tom Cahill

November 04, 2021

Presentation TCT 2021

Case Outcome

Presenter: Aakriti Gupta

November 04, 2021

Presentation TCT 2021

Case Presentation: 70-Year-Old With Severe Symptomatic Primary MR and Intermediate Surgical Risk

Presenter: Aakriti Gupta

November 04, 2021

Presentation TCT 2021

Case Outcome

Presenter: Yousif Ahmad

November 04, 2021

Presentation TCT 2021

What the Guidelines Say

Presenter: Davide Capodanno

November 04, 2021

Advertisement

TCT 774: Gender Differences in Prevalence, Clinical Presentation, Management Strategies and Clinical Outcomes of Valvular Heart Disease in Hospitalized Patients

TCT 609: Mortality Trends Due to Non-Rheumatic Valvular Disease Among Adults in the United States From Year 1999-2020: CDC WONDER Database Survey Analysis

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

TCT 630: Mitral Transcatheter Edge-to-Edge Repair in Multiple Valvular Heart Disease: Outcomes With Combined Aortic Insufficiency and Mitral Regurgitation

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Using AI-Based Analysis of ECGs and Multimodality Datasets to Improve Diagnosis of Valvular Heart Disease, Cardiac Amyloidosis, and Heart Failure

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

Hemodynamics for Valvular Heart Disease 101: Recognizing Hemodynamics Associated With Valve Disease

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR?

Case Outcome

What the Guidelines Say

Case Presentation: 79-Year-Old Woman With Mechanical MVR, Severe TR and Early RV Dysfunction

Case Outcome

Case Presentation: 70-Year-Old With Severe Symptomatic Primary MR and Intermediate Surgical Risk

Case Outcome

What the Guidelines Say

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content